PhD position / Postdoc position (m/f/d) in Cancer Genomics and Oncogenic Signaling

TUM Klinikum Rechts der Isar; Deutschland; Vor Ort; EUR 60.000 - 80.000; Vollzeit

Zusammenfassung

A university hospital in Munich seeks a candidate for a PhD/Postdoc position in Cancer Genomics and Oncogenic Signaling. The role involves genomic technology development, working with experimental design, and engaging in cancer research. Applicants should have a solid foundation in molecular biology techniques and experience in data analysis and scientific writing. This position offers a temporary contract with the opportunity to work in a vibrant and interdisciplinary environment.

Leistungen

Corporate benefits and discounts

Cafeteria

Sports and cultural offers

Company bike

Pension plan through VBL

Library access

Qualifikationen

• Strong background in molecular and cellular biology techniques.
• Experience with experimental design, data analysis, and scientific writing.

Aufgaben

• Genomic technology development focusing on functional genomic screening.
• Conduct CRISPR-based disease modeling in cells and organisms.
• Work in multidisciplinary teams within a creative environment.

Kenntnisse

Molecular and cellular biology techniques

Experimental design

Data analysis

Scientific writing

Jobbeschreibung

Your university hospital in the heart of Munich

We are the TUM Klinikum Rechts der Isar and a reliable employer for around 6,600 employees. As a university hospital, we are dedicated not only to patient care but also to research and teaching – in line with our mission statement "Knowledge creates healing" and enjoy an excellent reputation both nationally and internationally. 160 different professional groups work hand in hand to provide our patients with optimal treatment.

PhD position / Postdoc position (m/f/d)
in Cancer Genomics and Oncogenic Signaling

Full- or part-time | temporary (12 month) | Institute of Molecular Oncology and Functional Genomics

Our research is focused on gene discovery, functional gene annotation and signaling in cancer. We study biological processes, such as malignant transformation, tumour evolution, metastasis or drug response and resistance. See examples in: Nature 2018 Feb 1;554(7690):62, Nature Reviews Cancer 2020, Oct;20(10):573. Cancer Cell. 2023 Jul 10;41(7):1327; Nat Methods. 2024 Apr;21(4):584.

We develop and deploy genetic technologies and bioinformatics methods for high-throughput applications, such as genome-scale screening approaches using CRISPR or transposon systems. We are also running a sequencing facility and conduct translational studies using human samples or genetically engineered model organisms. Multidisciplinary teams of cancer biologists, mouse modelers, clinicians, molecular geneticists, sequencing experts and bioinformaticians are working closely together in a highly creative environment.

• Genomic technology development – with a focus on functional genomic screening Cancer genetics/biology, including CRISPR-based disease modelling in cells and organisms Cellular signalling and cancer therapy

Your profile:

• Strong background in molecular and cellular biology techniques Experience with experimental design, data analysis, and scientific writing

We offer you:

• EGYM well pass, corporate benefits and discounts (e.g. Käfer), cafeteria, sports and cultural offers, company bike Free use of the library through a branch of the Munich City Library located in the building Working in the heart of Munich at Max-Weber-Platz with very good accessibility by public transport such as the subway, S-Bahn or tram Company pension plan through the Federal and State Pension Institute (VBL) Self-realization through a varied and technically demanding job with interdisciplinary cooperation between various departments of the TUM Klinikum Rechts der Isar

We look forward to your application!

Contact: Prof. Roland Rad | Institute of Molecular Oncology and Functional Genomics

Please submit your complete application documents by e-mail including

• reference number 25_11_024 and your preferred starting date.

Institute of Molecular Oncology and Functional Genomics
TUM Klinikum
Rechts der Isar
Ismaninger Straße 22
81675 München
E-Mail: [e-mail]

If the candidates’ suitability for the position in question is equal, severely disabled applicants shall be given preference. Interview-related costs can, unfortunately, not be reimbursed.